Maxime Taquet

Recombinant shingles vaccination and the risk of cardiovascular events

Abstract The recombinant herpes zoster (shingles) vaccine may reduce risks of cardiovascular disease. However, existing studies have compared vaccine recipients with non-recipients and, thus, are susceptible to confounding. To mitigate these biases, we conducted a natural experim...